Effect of Suppressive Levothyroxine Therapy on Bone Mineral Density in Young Patients with Differentiated Thyroid Carcinoma

Suppressive levothyroxine therapy (sT4) is a cornerstone in the management of differentiated thyroid cancer (DTC). Long-term sT4 may affect bone mineral density (BMD). We evaluated the effect of sT4 on the bone mass of young DTC patients. In this cross-sectional study, BMD was evaluated via dual-ene...

Descripció completa

Dades bibliogràfiques

Autors principals:	André Borsatto Zanella, Laura Marmitt, Tayane Muniz Fighera, Rafael Selbach Scheffel, Poli Mara Spritzer, José Miguel Dora, Ana Luiza Maia
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2022-09-01
Col·lecció:	Metabolites
Matèries:	differentiated thyroid carcinoma pediatric patients suppressive levothyroxine bone density
Accés en línia:	https://www.mdpi.com/2218-1989/12/9/842
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!